Adult-onset Still's disease (AOSD) is a rare inflammatory condition characterized by fever, rash, and joint pain, often requiring a multifaceted treatment approach. The primary treatments include corticosteroids to quickly reduce inflammation and symptoms, along with non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying anti-rheumatic drugs (DMARDs) like methotrexate. Biologic therapies such as anakinra and tocilizumab are also increasingly utilized, particularly for patients who do not respond to conventional treatments. The benefits of these treatments include improved quality of life and reduced disease activity. Dr. Shallu Verma, an experienced rheumatologist, specializes in managing AOSD and employs a tailored approach that may include biologics to achieve better outcomes for her patients, ensuring comprehensive care throughout their treatment journey.
For more details please contact us at +919654364065